Tradestie Institutional Equity Comparison Engine

RIOX vs CIFU โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RIOX Overall Edge

RIOX Captures Institutional Edge (2โ€“0 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Defiance Daily Target 2X Long RIOT ETF (RIOX) driven by superior Momentum & Technical, Options & Structure. Fundamentally, RIOX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CIFU at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, RIOX sits in UNCLASSIFIED (15th %ile IV; Dealer Gamma Walls on Pro) against CIFU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RIOX N/M vs CIFU N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner RIOX
1Y -10.9% vs -97.0% ยท 52W Pos 10% vs 0%
Options & Structure Winner RIOX
UNCLASSIFIED (15th %ile IV) vs UNCLASSIFIED (N/A IV)
RIOX NYSE Arca
Defiance Daily Target 2X Long RIOT ETF
Institutional Equity
$12.28
-17.47% 1D
Market Cap N/A
1M Return +39.7%
1Y Return -10.95%
Forward P/E N/M
Unified AI Score
29.8 / 100 SELL
Tech 15.0 Fund 34.0 Flow 50.0 Mom 50.0
CIFU US Equity
CIFU
Institutional Equity
$0.72
-33.71% 1D
Market Cap N/A
1M Return -67.16%
1Y Return -96.96%
Forward P/E N/M
Unified AI Score
42.0 / 100 HOLD
Tech 25.0 Fund 52.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RIOX -10.95% CIFU -96.96% Spread: +95.99 pp (RIOX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RIOX TTM Op. Margin: N/A CIFU TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RIOX vs CIFU. Trailing 12-month operating profitability (RIOX N/A vs CIFU N/A) and valuation multiples (RIOX N/M vs CIFU N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RIOX (2) vs CIFU (1)
Institutional Metric RIOX CIFU Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 10% ($5โ€“$73) 0% ($1โ€“$51) Stronger Trend RIOX
Beta / 30D Volatility Risk Regime 6.16ฮฒ ยท 222% Vol 7.28ฮฒ ยท 314% Vol Lower Realized Risk RIOX
Unified Institutional Score Composite Signal 29.8 / 100 (SELL) 42.0 / 100 (HOLD) Higher Composite CIFU

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RIOX vs CIFU Buy Guide
RIOX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live RIOX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CIFU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CIFU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RIOX nor CIFU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.